Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...
The Food and Drug Administration (FDA) announced on July 12 that it is updating the label on the Johnson & Johnson COVID-19 vaccine to include a warning about the risk of developing Guillain-Barré ...
As millions of people get vaccinated against COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are closely monitoring reports of side ...
Experts say there has been an increase in a rare syndrome called Guillain Barré in Peru. The condition can occur when the immune system attacks the nervous system after either a viral or bacterial ...
Not all Guillain-Barré cases are associated with infection, and studies have suggested a link between the rare disorder and certain cancers, including lymphomas. Certain cancers, such as lymphomas, ...
Amid the near-total Israeli blockade, those in Gaza are facing a new threat to their lives — paralytic diseases. According to Nasser Hospital’s head of pediatrics, Dr. Ahmed Al-Farra, “Before the war, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback